When it comes to buying CBD oil, you must be exceedingly cautious because there is a tremendous amount of misinformation and outright deceit within the industry. Many online resources may try to mislead you for profit or other disingenuous reasons. For instance, some Cannabidiol oil companies advertise that their products contain a specific concentration of CBD (displayed in either percentages or milligrams (mg). However, independent research has shown that many of these sellers and their products do not live up to their claims as their products contain far less CBD than they state in print. The Food and Drug Administration (FDA) issued warning letters to specific companies in 2016 because their products were found to contain far less CBD than advertised.
It’s safe to say that Charlotte’s Web is probably the most recognized CBD brand out there — and it’s not all hype. This company pioneered the CBD industry and made it their mission to de-stigmatize CBD by setting the bar high for transparency. They produce and oversee their organic CBD products from seed to sale, standing behind them with a solid return policy.
Pure Hemp Botanicals’ mission statement is “compassion in action” – and it’s a pledge that it aims to adhere to not only through the use of organic hemp and cruelty-free ingredients, but also through its employment practices. The company’s “PHD Gives Back” initiative demonstrates a commitment to kindness, too, as 1 percent of proceeds from the sale of its products are donated to non-profit Mercy For Animals. Pure Hemp Botanicals’ range of CBD-containing goods is also varied, taking in as it does concentrates, vape oils and flavored mints and teas. And regular CBD oil users can, furthermore, take advantage of the company’s handy subscription system for tinctures, capsules and softgels – a scheme that’s not only convenient but which, thanks to the discounts available, offers a less costly way to get a CBD hit.
According to Ananda Hemp’s website, it’s something of a trailblazer in the CBD world, for it possesses what it maintains to be the U.S.’ first officially authorized hemp farm. Ananda Hemp also claims to be the earliest business to have legally imported its own hemp seeds – taken from what is said to be the most extensive privately owned cannabis seed bank in the world. This, the company says, “stands in contrast to many of [its] competitors, who are sourcing questionable, non-certified and untraceable CBD sources.” In any case, people who wish to see how Ananda Hemp’s process impacts on its products can see for themselves by using its full-spectrum extracts, softgels and topical salve. Those goods have themselves, it seems, been through the testing process a minimum of three times to ensure that their levels of potency live up to what’s written on the labels.
CBD oil fans who switch between vaping and sublingual use are ably catered for by CBD Drip. That’s because the company sells an innovative range of full-spectrum oils that can not only be mixed with regular e-liquids or vaped by themselves but which may also be added to food and drink or simply applied under the tongue. For individuals who’d rather make up their own CBD oil-infused products, meanwhile, the company even offers concentrate in bulk. And CBD Drip assures its customers as to the purity and efficacy of its merchandise by explaining in detail on the website what is tested for and why; full lab results for many of its goods are also available to view at a click.
In a separate publication, Brazilian researchers conducted a large-scale study on contemporary academic data involving the use of CBD as an anxiolytic (anxiety reducer). After reviewing dozens of global published studies in English, Spanish, and Portuguese, it was determined that a “clear anxiolytic-like effect of CBD [exists],” and that CBD was “shown to reduce anxiety in patients with social anxiety disorder.”
Your product is not generally recognized as safe and effective for the referenced uses and, therefore, the product is a “new drug” under section 201(p) of the Act [21 U.S.C. § 321(p)]. New drugs may not be legally introduced or delivered for introduction into interstate commerce without prior approval from the FDA, as described in section 505(a) of the Act [21 U.S.C. § 355(a)]; see also section 301(d) of the Act [21 U.S.C. § 331(d)]. FDA approves a new drug on the basis of scientific data submitted by a drug sponsor to demonstrate that the drug is safe and effective.